A handful of Canadian marijuana companies are already knee-deep in California, deploying millions of dollars in cultivation facilities, retail outlets and branded products to establish a footprint in the world’s largest marijuana market. Executives at the companies – whose shares trade on the Canadian Securities Exchange (CSE) – said they hope to capitalize on: Access to […]Read More
A New York-based marijuana investment company used cash and its Canadian-listed shares to fund a $48 million acquisition of a licensed medical marijuana business in Florida. iAnthus Capital Holdings, an investor in U.S. marijuana businesses, bought Florida’s GrowHealthy Holdings for $30.5 million in stock and $17.5 million in cash. GrowHealthy and its affiliate, McCrory’s Sunny Hill […]Read More
Prince Edward Island has tapped three licensed producers to supply it with marijuana, while the province plans to sell adult-use cannabis products through four government-owned stores when sales are legalized this year. The move means neighboring Newfoundland will be the only province east of Manitoba to involve the private sector in marijuana sales. In announcing its […]Read More
An umbrella group for Canada’s securities regulators is reviewing whether its disclosure-based guidelines for companies with U.S. marijuana-related activities remain appropriate in light of Attorney General Jeff Sessions’ decision to revoke Obama-era protections for state-legal MJ businesses. The move by the Canadian Securities Administrators (CSA) comes after the organization issued disclosure-related guidelines last fall. Fifty-six […]Read More
One of Canada’s largest licensed medical marijuana producers got even bigger, buying rival British Columbia cultivator Broken Coast Cannabis for 230 million Canadian dollars ($185 million) in stock and cash. Aphria, based in Leamington, Ontario, also expanded its presence in Australia, purchasing a 25% stake in an Australian MMJ producer for CA$2.5 million. Aphria’s acquisition […]Read More
Quebec’s nascent marijuana industry may be home to a disproportionately small number of licensed producers and off-limits to entrepreneurs in the retail sector, but that doesn’t mean the province lacks opportunity.
You just need to know where to look, particularly among cannabis-related ancillary businesses.
The province’s medical market, for one, has nowhere to go but up.Read More
Demand for medical marijuana in Germany is surging, opening new opportunities for overseas companies. Canadian MMJ companies, in particular, have been quick to position themselves to meet a supply shortfall in Germany. By the end of 2017, a total of 13,000 patients had applied for medical marijuana reimbursements from three large health insurance companies, Rheinische Post reported. […]Read More
A major Canadian licensed producer has sealed an arrangement with a Dutch pharmaceutical distributor to market and sell its medical marijuana products in 17 countries. Saskatchewan-headquartered CanniMed Therapeutics, traded on the Toronto Stock Exchange as CMED, entered into a global marketing and distribution agreement with Fagron NV of the Netherlands. Financial terms were not disclosed. Under […]Read More
If a recreational marijuana shortage materializes in Canada come 2019 – as most industry observers predict – don’t blame Health Canada, which more than doubled the number of production licenses it granted in 2017.
Instead, look to regional supply imbalances – possibly in provinces that opt to sell adult-use cannabis through government-run retail outlets – and producers who fail to live up to their cultivation targets.Read More
A Canadian medical marijuana company secured a deal with Germany’s CC Pharma GmbH to export MMJ products for distribution through thousands of German pharmacies. Nuuvera Inc. – which has a strategic partnership with Aphria (TSE: APH) to build a 1-million-square-foot greenhouse – will supply approximately 1,200 kilograms of medical cannabis to CC Pharma, which distributes pharmaceuticals to over […]Read More
Saskatchewan’s adult-use marijuana will be sold in private brick-and-mortar stores and online, the government announced, giving entrepreneurs in the cannabis space more opportunities when sales begin this summer. Saskatchewan is the last Canadian province to announce plans for marijuana sales. However, major decisions on home cultivation, taxation, a minimum age for cannabis consumption and public-use […]Read More
An exchange in Canada dominated by marijuana stocks has asked listed companies with U.S. operations to publicly detail any risks they face after Attorney General Jeff Sessions’ decision to scrap protections for state-legal cannabis businesses. Richard Carleton, chief executive officer of the Canadian Securities Exchange, told Marijuana Business Daily that the exchange contacted all CSE-listed companies with […]Read More
- April 29, 2019April 26, 2019April 25, 2019
Read the Issue